Background
Methods
CRC patients
DNA extraction and genotyping
Haplotypes, tagging SNPs and association testing
Association tests for single markers
Haplotype reconstruction in cases and controls
Power estimates for association tests
Results
Familial CRC (n = 93) | Sporadic CRC (n = 150) | 'Hyper-normal' controls (n = 204) | |
---|---|---|---|
Age | 55 ± 11 | 66 ± 8 | 62 ± 7 |
Males: females | 51: 42 | 81: 69 | 91: 113 |
UICCC stage
|
(n = 61)
|
(n = 147)
| |
I | 13 (21.0%) | 34 (23.1%) | |
II | 9 (14.5%) | 52 (35.4%) | |
III | 26 (41.9%) | 48 (32.7%) | |
IV | 13 (22.6%) | 13 (8.8%) | |
Localisation
|
(n = 67)
|
(n = 144)
| |
Right Colon | 17 (25.4%) | 35 (28.9%) | |
Left Colon | 50 (74.6%) | 109 (71.1%) |
Association tests with single SLC10A2 variants
Tagging SNP | Variant | Minor allele frequency | P values | ||
---|---|---|---|---|---|
Familial CRC | Sporadic CRC | 'Hyper-normal' controls | |||
rs279941
| G>T | 0.14 | 0.10 | 0.13 |
# p = 0.78 * p = 0.27 |
rs183963
| A>T | 0.35 | 0.37 | 0.37 |
# p = 0.54 * p = 0.91 |
rs157266
| G>A | 0.13 | 0.11 | 0.14 |
# p = 0.86 * p = 0.20 |
rs1886927
| G>T | 0.09 | 0.08 | 0.09 |
# p = 0.98 * p = 0.67 |
Tagging SNP | Variant | Genotype frequency | Armitage trend test | ||
---|---|---|---|---|---|
Familial CRC | Sporadic CRC | 'Hyper-normal' controls | |||
rs279941
| GG | 0.74 | 0.82 | 0.76 | *p = 0.78 |
GT | 0.25 | 0.17 | 0.22 |
#p = 0.27 | |
TT | 0.01 | 0.01 | 0.02 | ||
rs183963
| AA | 0.46 | 0.39 | 0.43 | *p = 0.56 |
AT | 0.39 | 0.49 | 0.41 |
#p = 0.97 | |
TT | 0.15 | 0.12 | 0.15 | ||
rs157266
| GG | 0.74 | 0.80 | 0.76 | *p = 0.87 |
GA | 0.25 | 0.19 | 0.19 |
#p = 0.23 | |
GT | 0.01 | 0.02 | 0.05 | ||
rs1886927
| GG | 0.81 | 0.84 | 0.82 | *p = 0.98 |
GT | 0.19 | 0.15 | 0.17 |
#p = 0.67 | |
TT | 0.00 | 0.01 | 0.01 |
Haplotype reconstruction and association tests with common SLC10A2 haplotypes
Haploptype |
rs279941
|
rs183963
|
rs157266
|
rs1886927
| Haplotype frequency | ||||
---|---|---|---|---|---|---|---|---|---|
Hapmap project (Caucasians) | Familial CRC | Sporadic CRC | 'Hyper-normal' controls | Total study population | |||||
SLC10A2_1
| G | A | G | G | 0.48 | 0.52 | 0.53 | 0.50 | 0.52 |
SLC10A2_2
| G | T | A | A | 0.32 | 0.34 | 0.35 | 0.35 | 0.35 |
SLC10A2_3
| T | A | A | T | 0.13 | 0.09 | 0.07 | 0.08 | 0.08 |
SLC10A2_4
| T | A | A | G | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 |